 |
Independent Dispute Resolution (IDR) under the No surprises Act (NSA) has become a high-stakes game that can impact billions of dollars in healthcare reimbursements every year. Given the opportunity and risk involved, being able to determine optimal NSA arbitration offers has become an important capability for both payers and providers. To help with the challenge of NSA arbitration and negotiation, Genpact has built a supervised learning solution — ‘Predict to Win’—leveraging benchmark pricing, historical arbitration cases and other relevant data to recommend optimal price offerings that increase arbitration win rates and associated payer savings or provider reimbursements. |
